Hong Kong biotech firm races to develop chikungunya fever test for early detection
Hong Kong is developing a rapid test for chikungunya fever that could detect the disease at an earlier stage, as part of the city’s efforts to harness technology to combat the public health risk. Ricky Chiu Yin-to, founder and CEO of biotechnology company Phase Scientific, said on Monday that his team was working to develop…